Home › Cholesterol › Texas
Pag-aaral pangklinika para sa Cholesterol sa Texas
6 pag-aaral para sa Cholesterol ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- at 8 pa
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- at 3 pa
Nagre-recruitPhase 3
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research Dallas, Dallas
- Valley Institute of Research, Rockwood Medical Clinic, Fort Worth
- Be Well Clinical Studies - Round Rock, Round Rock
- at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07477704Multicomponent Intervention Study- Blood Donors With High Cholesterol
- UT Southwestern Medical Center, Dallas
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT05693701Alirocumab in Patients on a Stable Dialysis Regimen
- Baylor Soltero CV Research, Dallas
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Peb 12, 2020 · NCT03480568Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.